vidarabine has been researched along with 9-xylosyladenine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cristalli, G; Esker, JL; Jacobson, KA; Ji, XD; Melman, N; Olah, ME; Schneller, SW; Secrist, JA; Siddiqi, SM; Tiwari, KN | 1 |
Casolaro, V; Marone, G; Petracca, R; Vigorita, S | 1 |
Condorelli, M; Marone, G; Triggiani, M; Vigorita, S | 1 |
Gosselin, G; Goswami, BB; Imbach, JL; Sharma, OK | 1 |
4 other study(ies) available for vidarabine and 9-xylosyladenine
Article | Year |
---|---|
Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.
Topics: Adenosine; Animals; Cell Membrane; CHO Cells; Corpus Striatum; Cricetinae; In Vitro Techniques; Magnetic Resonance Spectroscopy; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Radioligand Assay; Rats; Recombinant Proteins; Ribose; Structure-Activity Relationship | 1995 |
Adenosine receptors of human leukocytes--II. Characterization of an inhibitory P-site.
Topics: Adenosine; Adenylyl Cyclases; Adult; Cells, Cultured; Cyclic AMP; Dideoxyadenosine; Enzyme Activation; Humans; Lymphocytes; Neutrophils; Purinergic Antagonists; Receptors, Purinergic; Vidarabine | 1990 |
Adenosine receptors on human lymphocytes.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Alprostadil; Binding Sites; Colforsin; Cyclic AMP; Deoxyadenosines; Dideoxyadenosine; Histamine; Humans; In Vitro Techniques; Isoproterenol; Lymphocytes; Manganese; Neutrophils; Receptors, Purinergic; Theophylline; Vidarabine | 1986 |
Mechanism of inhibition of herpesvirus growth by 2'-5'-linked trimer of 9-beta-D-xylofuranosyladenine.
Topics: Acyclovir; Adenosine; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Kidney; Simplexvirus; Species Specificity; Transcription, Genetic; Vidarabine | 1984 |